The ubiquitous valosin-containing protein (p97/VCP) is a prominent member of the highly conserved AAA ϩ (ATPases associated with diverse cellular activities) proteins, which are known for their oligomeric structure and chaperone-like activities. p97/VCP is an essential biochemical component of a wide range of ubiquitin-linked cell biological reactions, including ubiquitin-proteasome system-mediated protein degradation (8) , Golgi and endoplasmic reticulum (ER) membrane fusion (1, 18) , transcription factor activation (19) , and DNA repair (10, 16) . In these processes, p97 acts as a molecular segregase that utilizes ATP-powered conformational changes in the assembly and disassembly of macromolecular machineries (8, 11) .
p97 ATPase activity is contingent on the assembly of an inherently stable hexamer (24) comprised of two highly homologous D1 and D2 nucleotide-binding rings and regulatory NH 2 -and COOH-terminal domains (4) . ATP hydrolysis in the D2 ring mediates p97 major ATPase activity, while the D1 ring is involved in the regulation of p97 hexamerization (24) . Recently, p97 has been linked to a severe degenerative disorder identified as hereditary inclusion body myopathy associated with early-onset Paget disease of bone and frontotemporal dementia (hIBMPFTD). The pathogenesis of hIBMPFTD is attributed to autosomal-dominant single-amino-acid substitutions in highly conserved residues within the p97 NH 2 domain and D1 ring (28) . Patients present with hallmark features of a "protein conformational" disorder in which proteinaceous inclusions accumulate in the cytoplasm and nuclei of degenerating myofibrils (13) and dystrophic neurites (7, 15, 23) . Transgenic expression of hIBMPFTD p97 mutants in a murine model sufficiently recapitulates these inclusions (31) . While the ultrastructure and composition of hIBMPFTD inclusions are poorly defined, several reports have identified p97/VCP and ubiquitin as major constituents (12, 28, 32) . Furthermore, overexpression of hIBMPFTD mutants in C2C12 skeletal myoblasts results in p97 localization to cytoplasmic inclusions and fractionation with insoluble proteins (30) . One possibility is that misfolding or misassembly directly mediates p97/VCP accumulation in inclusion bodies, which in turn nucleates the entrapment of its interacting proteins. Alternatively, the biogenesis of p97-containing inclusions could represent an indirect consequence of failure in other p97/VCP-dependent pathways upstream of the ubiquitin-proteasome system. The mechanisms by which hIBMPFTD p97 mutants induce the biogenesis of inclusion bodies in cell culture models are not well understood (9, 30) .
Despite current progress in resolving more refined p97/VCP crystal structures in various nucleotide-binding states (3, 5) , clues about how hIBMPFTD mutations impact p97 structure or conformation remain elusive. Cryo-electron microscopy (cryo-EM) (21, 22) and crystallography studies (4, 5) of p97 in various nucleotide-binding states have revealed extensive communication between the tripartite NH 2 -D1-D2 domains (17) . Conformational changes first initiated in the D2 ring are relayed through a D1-D2 linker region to the D1 ␣-helical subdomain. The D1 ␣-helical subdomain in turn communicates these motions to the flexibly linked NH 2 domain, thereby regulating its conformation (5) . Ultimately, these ATP-powered conformational changes are utilized in remodeling macromolecular complexes. One hypothesis is that hIBMPFTD mutations interfere with p97/VCP biochemical activity by altering its conformation or interdomain communication. For , all of which are now identified as mutated residues in hIBMPFTD (5, 9) . However, it remains to be seen whether hIBMPFTD mutations do indeed induce structural or conformational defects in p97/VCP.
In this report, we specifically focused on studying hIBMPFTD p97 R155P and p97 A232E mutants because Arg 155 is the most commonly affected amino acid residue and mutation of Ala 232 is associated with increased severity of the disease (13, 28) . A series of biochemical approaches were employed to characterize the oligomeric assembly, ATPase activity, and solution structure of wild-type (p97 WT ) and mutant p97. Our results indicate that recombinant p97 R155P and p97 A232E assembled into ϳ600-kDa complexes, similar to p97
WT . Both mutants showed a threefold increase in ATPase activity and increased sensitivity to heat-induced upregulation in ATPase activity. Analysis of the intrinsic protein fluorescence and proteolytic susceptibility provided evidence for conformational defects in the D2 ring. These effects were correlated with increased propensity for aggregation in the presence of ATP. Based on these data, we propose that hIBMPFTD p97 mutations induce structural defects, which may underlie the mechanism of pathogenesis in biological systems.
MATERIALS AND METHODS
Generation of p97/VCP recombinant expression constructs. A wild-type murine p97 cDNA clone in pBluescript SK(ϩ) was a kind gift of Fred Indig (National Institute on Aging, NIH, Baltimore, MD). To introduce hIBMPFTD mutations, p97cDNA was subjected to site-directed mutagenesis using the GeneTailor kit according to the manufacturer's instructions (Invitrogen, Carlsbad, CA). For the R155P mutation, G 464 in codon 463 CGG 465 was replaced with C using the following primers: 5Ј AGGAGATATTTTTCTTGTCCCGGGTGGGATG 3Ј and 5Ј GGACAAGAAAAATATCTCCTTTACGGATGGGCC 3Ј. For the A232E mutation, C 695 in codon 694 GCG 696 was mutated to A using primers 5Ј ACATCC TGCGCTCTTCAAGGAGATTGGTGTA 3Ј and 5Ј CCTTGAAGAGCGCAGG ATGTCTCAGTGGCAGCT 3Ј. cDNA of the ATP-binding-deficient mutant p97 K524A in the pQE9 vector was a kind gift from T. Rapoport (Harvard University, Cambridge, MA). Subsequently, all constructs were subcloned into the pTrcHis2C vector backbone (Invitrogen, Carlsbad, CA) for COOH-terminal polyhistidine tagging by PCR. Briefly, cDNA was amplified using the primers 5Ј CCGAGCTCGG CCTCTGGAGCCGAT 3Ј and 5Ј ATGGTACCAGCGGCATACAGGTCATC 3Ј, which contained SacI and KpnI restriction sites, respectively. Following restriction digestions, the PCR products were ligated into the pTrcHis2C multiple-cloning site. Insertion of the cDNA was verified by restriction digestion, which was followed by full sequencing (McGill University and Genome Quebec Innovation Center, Montreal, Canada).
Expression and purification of recombinant p97/VCP. p97 WT and mutant variants were expressed in the TOP10 Escherichia coli strain. Overnight starter cultures were diluted 50-fold in 2 liters of 2ϫ YT medium (16 g/liter tryptone, 10 g/liter yeast extract, 5 g/liter NaCl) with 100 g/ml ampicillin and grown at 37°C until they reached an optical density at 600 nm of 0.6. The cultures were subsequently induced with 300 M IPTG (isopropyl-␤-D-thiogalactopyranoside) and grown for another 4 h. The cells were pelleted by centrifugation (4,000 ϫ g for 20 min) and lysed in buffer A (20 mM HEPES, pH 7.5, 300 mM NaCl, 5 mM MgCl 2 , 2.5 mM dithiothreitol [DTT] , and 20 mM imidazole) supplemented with 1 mg/ml lysozyme and complete protease inhibitors (Roche, Mississauga, Canada). Following sonication, the lysates were cleared by centrifugation at 26,000 ϫ g for 45 min. The supernatant was then loaded on a 5-ml Ni 2ϩ affinity column (GE Healthcare Biosciences, Uppsala, Sweden) preequilibrated with 10 column volumes of buffer A. Following a first wash with 10 column volumes of buffer A, bound proteins were subjected to an additional wash with 10 column volumes of buffer B (20 mM HEPES, pH 7.5, 300 mM NaCl, 5 mM MgCl 2 , 2.5 mM DTT, and 35 mM imidazole). The proteins were eluted with a 35 to 500 mM imidazole gradient over 5 column volumes. Peak fractions containing p97 were pooled, concentrated on an Amicon Ultra column (molecular mass cutoff, 15,000 kDa), and loaded on a precalibrated 100-ml Superose-6 gel filtration column (GE Healthcare Biosciences, Uppsala, Sweden). Size-fractionated proteins were eluted as 1-ml fractions in buffer C (20 mM HEPES, pH 7.5, 150 mM NaCl, 5 mM MgCl 2 , and 2.5 mM DTT). All purifications were performed at 4°C using the UKTA fast-performance liquid chromatography purification system (GE Healthcare Biosciences, Uppsala, Sweden). Protein concentrations were determined using the Bradford assay (BioRad, Mississauga, Canada).
Native gel electrophoresis. Ten micrograms of purified recombinant p97 WT or mutant variants was loaded on a 6% Tris-polyacrylamide gel (pH 8.0). Electrophoresis was performed at 4°C using 200 V and ice-cold 1ϫ Tris-glycine buffer (pH 8.0) to prevent heat-induced denaturation.
Negative-staining EM. p97 proteins were diluted to a concentration of 50 g/ml in buffer containing 20 mM HEPES, pH 7.5, 150 mM NaCl, 10 mM MgCl 2 , and 1 mM DTT in the presence or absence of 1 mM ATP (Sigma, Oakville, Ontario, Canada). For each protein, a 5-l sample was spotted on a glowdischarged carbon-coated copper grid. The grids were then stained for 60 s with 5 l of uranyl acetate and visualized using an FEI Tecnai 12 120-kV electron microscope. Digital images were collected with a Gatan 792 Bioscan 1,000 by 1,000 wide-angle multiscan charge-coupled device camera. Images were cropped at the level of the scale bar to show ϳ25% of the full image.
Dynamic-light-scattering (DLS) measurements. p97 protein samples were diluted to 100 g/ml in buffer containing 20 mM HEPES, pH 7.5, 150 mM NaCl, 10 mM MgCl 2 , and 1 mM DTT in the presence or absence of 2 mM ATP. Measurements were performed using the Zetasizer Nano ZS (Malvern) at 20°C.
ATPase activity assays. p97 ATPase activity was assessed using the EnzCheck phosphate assay kit (Molecular Probes, OR) as previously described (6) . This assay is based on the inorganic-phosphate-dependent conversion of 2-amino-6-mercapto-7-methylpurine riboside to ribose-1-phosphate and 2-amino-6-mercapto-7-methylpurine, which results in a shift of the maximum absorbance from 330 nm to 360 nm (29) . For assessment of p97 ATPase activity, 50 nM of p97 (based on the ϳ600-kDa hexamer) was incubated in 100 l reaction buffer (20 mM HEPES, pH 7.5, 150 mM NaCl, and 10 mM MgCl 2 ) containing 200 M of ATP. Parallel reactions were set without the addition of ATP to correct for background absorbance values. The absorbance at 360 nm was then measured at 20-s intervals for a total of 20 min at the physiological temperature of 37°C or 42°C for heat induction. The amount of inorganic phosphate released was quantified based on a KH 2 PO 4 standard curve of 0 to 80 M set in 100 l reaction buffer. All reactions were preformed in duplicate for each experiment.
Protein fluorescence spectroscopy. The intrinsic protein fluorescence was determined using the Edinburgh FLS-920 fluorometer. Protein samples were diluted to 62.5 g/ml in buffer containing 20 mM HEPES, pH 7.5, 150 mM NaCl, 10 mM MgCl 2 , and 1 mM DTT in the presence or absence of 2 mM ATP. The excitation wavelength was set at 295 nm, while fluorescence emission was monitored between 305 nm and 450 nm. The excitation and emission slits were set at 5 nm, and the measurements were performed using a high photomultiplier tube voltage setting. All measurements were performed at 20°C and corrected for background emission values. Four independent measurements were performed, each in triplicate, for each p97 protein variant.
Limited-proteolysis assay and Western blot detection. Proteolysis reactions were performed at 37°C in a total volume of 50 l containing 5 g of p97, 250 ng of trypsin, and reaction buffer (20 mM HEPES, pH 7.5, 150 mM NaCl, 10 mM MgCl 2 , and 1 mM DTT) in the presence or absence of 1 mM ATP for the indicated time intervals. The reactions were terminated by the addition of 0.5 mM phenylmethylsulfonyl fluoride and the reaction mixtures were boiled in 1ϫ sodium dodecyl sulfate (SDS) loading buffer. Samples were subsequently subjected to SDS-polyacrylamide gel electrophoresis (PAGE) and transferred to polyscreen polyvinylidene difluoride membranes (Perkin Elmer, Zaventem, Belgium). Following blocking in 5% nonfat milk, the membranes were incubated in a monoclonal anti-p97 antibody at a dilution of 1:1,000 (BD Transduction Laboratories, San Jose, CA) for 1 h at room temper-VOL. 29 WT with or without 250 ng of trypsin in buffer containing 20 mM HEPES, pH 7.5, 150 mM NaCl, 10 mM MgCl 2 , 1 mM DTT, and 1 mM ATP. Reaction mixtures were set in 50 l volumes and incubated at 37°C for 60 min. Following termination with 0.5 mM phenylmethylsulfonyl fluoride, samples were boiled in 1ϫ SDS loading buffer and subjected to SDS-PAGE, followed by Coomassie staining. The stained bands were excised and analyzed at the Institut de Recherches Cliniques de Montréal proteomics discovery platform (Montréal, Canada).
Statistical analysis. Analysis of variance was conducted, followed by the Scheffé post hoc test or Tukey/Kramer analysis. Data were designated statistically significant only if the P value was equivalent to or less than 0.05. All tests were conducted using StatView 5.0 software (SAS Institute Inc., Cary, NC).
RESULTS hIBMPFTD p97 mutants p97
R155P and p97 A232E form hexameric complexes similar to p97 WT in vitro. To investigate the oligomerization patterns of p97 R155P and p97 A232E , recombinantly expressed p97 proteins, first purified on a metal affinity column, were size fractionated by gel filtration chromatography ( Fig. 1A and B). p97
WT , the hIBMPFTD mutants p97
R155P
and p97 A232E , and an ATPase-deficient mutant, p97 K524A , all eluted in two peaks: a minor peak within the void volume ( Fig.  1A and B, peak 1) (ϳ37 to 43 ml) and a major peak overlapping with the 670-kDa thyroglobulin complex ( Fig. 1A and B, peak 2) (ϳ47 to 63 ml). Further analysis of the major peak fraction by native gel electrophoresis also demonstrated that both p97 R155P and p97 A232E comigrated with p97 WT and the thyroglobulin complex (Fig. 1C) . Interestingly, p97 K524 , which encompasses a mutation abolishing ATP binding in the D2 ring, could not be resolved under the native gel electrophoresis conditions used. These results indicate that p97
WT and the hIBMPFTD mutants formed ϳ600-kDa complexes consistent with hexameric assembly. To confirm ring-shaped assembly, the hexameric protein peaks (Fig. 1D) were analyzed by negative-staining EM. At ϫ160,000 magnification, p97 R155P , p97 A232E , and p97 K524A showed relatively homogeneous populations of ring-shaped particles notably similar to p97 WT (Fig.  1E, top) . ATP binding had no effect on the ring-shaped assembly of p97 WT or mutant variants (Fig. 1E, bottom) . Furthermore, all p97 protein samples contained some misfolded aggregates (not shown); however, there were no apparent differences in the structures or abundances of these aggregates between p97
WT and the mutant variants. Altogether, these results confirm that the hIBMPFTD p97 mutants and p97 K524A assemble into hexameric, ring-shaped complexes similar to p97
WT and display no inherent propensity for misassembly or aggregation.
hIBMPFTD mutants p97 R155P and p97 A232E confer a gainof-function phenotype on p97 total ATPase activity and alter its intrinsic fluorescence profile. The ATPase activities of p97 WT , p97 R155P , and p97 A232E were monitored under physiological temperature and saturating ATP concentrations. At 37°C, p97 R155P and p97 A232E displayed significantly higher ATPase activity than p97 WT ( Fig. 2A and C and Table 1 ). The ATP hydrolysis rates of p97 R155P and p97 A232E were similar and about three times higher than the rate of p97 WT (Fig. 2C  and Table 1 ). At 42°C, there was no significant increase in p97
WT ATPase activity; however, p97 R155P and p97 A232E displayed significant 1.7-and 1.4-fold increases, respectively (Fig. 2B and C and Table 1 ). Furthermore, p97
R155P 's heat-induced ATPase activity was significantly higher than that of p97 A232E ( Fig. 2C and Table 1 ). In contrast, p97
K524A displayed no measurable ATPase activity at either temperature ( Fig. 2A to C and Table 1 ). Collectively, these data show that the hIBMPFTD mutants p97 R155P and p97 A232E display not only elevated ATPase activity, but also increased sensitivity to heatinduced upregulation of ATPase activity.
To investigate if the upregulation in p97 ATPase activity was correlated with changes in the conformational state of the AAA ϩ rings, a qualitative analysis was performed using intrinsic protein fluorescence spectroscopy ( Fig. 3 and Table 2 ). In this assay, the change in protein fluorescence is inversely related to the hydrophobicity of tryptophan 476 (Trp 476 ) within the D2 ring (27) . In the absence of ATP binding, only p97
showed significantly higher total fluorescence emission than p97 WT , which is indicative of increased basal accessibility of Trp 476 (Table 2 and Fig. 3A ). Both p97 A232E and p97 K524A also displayed higher total fluorescence emission than p97
WT , although it did not reach statistical significance (Table 2 and Fig.  3A) . Upon ATP binding, p97 R155P and p97 A232E displayed significantly higher total fluorescence than p97
WT , which reflected increased solvent accessibility of Trp 476 (Table 2 and Fig. 3B ). On the other hand, p97
K524A displayed significantly lower total fluorescence than p97
WT and both hIBMPFTDlinked mutants, which is consistent with its inability to bind ATP in the D2 ring (Fig. 3B and C and Table 2 ). Comparison of the ATP-dependent changes in total fluorescence showed that p97 R155P underwent the largest change in protein fluorescence ( Fig. 3C and Table 2 ). Altogether, these data suggest that p97 R155P undergoes the largest conformational change in response to ATP binding and that both p97 R155P and p97 WT and the hIBMPFTD mutants using a limited-proteolysis approach. Trypsin-mediated digestion of full-length p97 generated two predominant cleavage products, p87 and p58, both retaining a large NH 2 -terminal epitope (residues 9 to 130) (Fig. 4A) . Silver stain analysis ruled out the presence of additional cleavage products (Fig. 4B) .
Thus, p87 reflected the cleavage of the COOH-terminal domain, while p58 resulted from additional proteolysis of the D2 ring.
Comparison of proteolysis kinetics between p97
WT and p97
R155P
revealed similar susceptibility patterns in the absence of ATP addition, while p97 A232E and p97 K524A were more prone to proteolysis (Fig. 4A, left) . Specifically, p87 proteolysis was complete at 90 min for p97 A232E and p97 K524A compared to 120 min for p97
WT and p97 R155P ( Fig. 4A and B, left) . These data indicate that the conformation of the COOH-terminal domain and the D2 ring are more "labile" in p97 A232E and p97
K524A
. Furthermore, p97
WT showed an ATP-dependent delay in p87 and p58 degradation in which both cleavage products could be detected 120 min after the initiation of the reaction (Fig. 4A, right) . In contrast, p87 showed increased susceptibility to proteolytic cleavage in all p97 mutants, with p97 A232E and p97 K524A having the most accelerated degradation kinetics. Conversely, p58 was most strongly protected in p97 R155P relative to all other p97 variants.
To identify the approximate sites of proteolysis, p97, p87, and p58 were sequenced using mass spectrometry (Table 3) . (Table 3) . These results suggest that the increased proteolytic susceptibility of p87 in p97 R155P and p97 A232E is due to D2 ring destabilization between residues Lys 524 and Arg 709 (Fig. 4C) . hIBMPFTD p97 mutants, p97 R155P and p97 A232E , undergo ATP-dependent alteration in solution structure. In the absence of ATP, p97 particle size distribution consisted of two populations: a population of ϳ20-nm particles corresponding to assembled p97 ( Fig. 5A and Table 4 , peak 1) and a minor population reflecting large-diameter species (Fig. 5A and Table 4, peak 2). p97 R155P and p97 A232E showed distributions similar to that of p97 WT (Fig. 5A ) and displayed no significant differences in the estimated diameter of either assembled p97 or the large-diameter species (Table 4) . In all cases, the most abundant population reflected hexameric p97 and accounted for at least 80% of the total light-scattering intensity (Table 4 , peak 1). Interestingly, assembled p97 K524 and its large-diameter species both displayed significantly larger estimated diameters, with the assembled population accounting for at least 90% of the light-scattering intensity (Fig. 5A and Table 4 , peak1 and peak 2).
In the presence of physiologically relevant ATP concentrations, there were no significant changes in the solution structure of p97
WT . In comparison, the light-scattering intensity of assembled p97 R155P was significant reduced, and this effect correlated with an increase in the scattering intensity of the large-diameter population (Fig. 5B and Table 4 ). These results show an ATP-dependent shift toward increased abundance of the large-diameter population in p97 R155P . Furthermore, the estimated diameter of assembled p97 R155P was significantly reduced compared to p97 WT (Table 4) . Similarly, p97 A232E displayed a pronounced increase in the abundance of the largediameter population, which was correlated with a significant reduction in particle size ( Fig. 5B and Table 4 ). However, unlike p97 R155P , the diameter of assembled p97 A232E was significantly reduced compared to the ATP-unbound state, as well as assembled p97
WT (Table 4) . These effects were correlated with a significant increase in the heterogeneity of the population's size distribution profile, as reflected in the increased polydispersity index estimate (Table 4) . Therefore, ATP bind- ing changed the solution structure of p97 A232E and promoted the formation of large-diameter complexes. Moreover, the large-diameter population in p97 K524A displayed changes similar to those in p97 A232E ; however, despite the increased abundance of the large-diameter population in p97 K524A , both the size and light-scattering intensity were not significantly different from those of p97 WT (Table 4) .
Interestingly, compared to p97 WT , ATP binding significantly reduced the diameters of assembled p97 R155P and p97
A232E
but increased the diameter of p97 K524A (Table 4) . Altogether, these data provide evidence for ATP-dependent alterations in the solution structure of hIBMPFTD mutants and indicate that ATP binding may facilitate the formation of large-diameter species. 
DISCUSSION
hIBMPFTD is a degenerative disorder caused by single substitutions in highly conserved amino acid residues in the NH 2 domain and the D1 ring of p97/VCP (13, 28) . The affected residues are proposed to play roles in relaying conformational changes initiated in the D2 ring to adaptor protein complexes (5). These ATP-powered conformational changes (21, 22) , in turn, provide the mechanistic basis for p97 cell biological activity. In this study, we provide evidence for structural defects in the hIBMPFTD p97 mutants p97 R155P and p97 A232E . We show that both mutations upregulate p97 ATPase activity and increase sensitivity to heat-induced upregulation of ATPase activity. Using protein fluorescence analysis and a limitedproteolysis assay, we provide evidence for altered conformational states and destabilization of the D2 ring. We further show that these defects are correlated with a propensity for nucleotide-dependent aggregation of both mutants in solution. Based on these data, we propose that structural defects in p97/VCP may underlie the pathogenesis of hIBMPFTD.
hIBMPFTD p97/VCP mutations in Arg 155 and Ala 232 do not impair spontaneous self-assembly. Using size exclusion chromatography and native gel electrophoresis, we showed that hIBMPFTD mutants p97 R155P and p97 A232E assembled into hexameric complexes and ruled out the possibility of misassembly or deoligomerization. Visualization by EM further confirmed the ring-shaped structure of the pathogenic p97 mutants. These results are in agreement with a previous finding that p97 R155H does not display an oligomerization defect (30) and are consistent with the NH 2 domain being dispensable for hexamerization (22, 33) . We also showed that the p97 mutation A232E does not impair hexamerization, in spite of its localization in the D1 ring, which is necessary for p97 self-assembly (26) . Residue Ala 232 is positioned at the junction between the D1 domain and the NH 2 -D1 linker region (28) . This peripheral localization is inconsistent with a role in regulating interprotomer interaction within the D1 ring. Other works have demonstrated that p97 oligomerization is spontaneous and that nucleotide binding to the D1 ring stabilizes the hexamer (26) . The only single-amino-acid mutations known to prevent p97/ VCP assembly affect the D1 Walker A residue, Lys 251 (6, 25) , or the D1 second region of homology residue, Arg 362 (25 (6) . Together, our results suggest that the disease severity associated with mutation in Ala 232 in hIBMPFTD is likely unrelated to an oligomerization defect in p97/VCP. Interestingly, our data also suggest that p97 K524A may form higher ring-shaped oligomers than p97
WT or hIBMPFTD mutant variants. This is evident in its migration pattern on native gel electrophoresis and its significantly larger estimated diameter in solution. Recent work has demonstrated that the D2 ring adopts a heptameric structure with a sevenfold symmetry when purified independently of the NH 2 domain and the D1 ring (3). It is possible that disrupting nucleotide binding in the D2 ring may also alter the fold symmetry of p97/VCP. Alternatively, the p97 K524A mutation may alter the shape of the hexamer in a way that influences its native gel migration and increases its apparent diameter in solution.
hIBMPFTD p97 mutants p97 R155P and p97 A232E show increased ATPase activity. Under the conditions used, the specific ATPase activity of p97
WT was lower than the values previously reported (6, 14, 24) , although different expression, purification, and assay conditions were used. Nevertheless, our data show an ϳ3-fold increase in p97 R155P ATPase activities. In another report, the p97 R155H mutant displayed ATPase activity levels comparable to those of p97 WT , whereas heatinduced upregulation in ATPase activity was not assessed (30) . One explanation for this discrepancy is the nature of the amino acid change associated with Arg 155 . For example, DeLaBarre and colleagues showed that different amino acid substitutions for the D1 pore residue His 317 could have opposing effects on p97 ATPase activity, in spite of the fact that His 317 is not directly involved in ATP binding or hydrolysis (6) . Nevertheless, our results pose the possibility that the p97 NH 2 domain is involved in the positive regulation of p97 basal ATPase activity. The strong ATP-dependent protection of the p58 Nterminal fragment of p97 R155P in the limited-proteolysis assay suggests increased affinity for ATP binding in the D1 ring. Changes in nucleotide-binding affinity may alter the cooperativity between the D1 and D2 rings. Furthermore, previous studies demonstrated that some adaptor proteins binding to the p97 NH 2 domain (i.e., p47) downregulate p97 ATPase activity (14) , while others had no effect (i.e., Npl4/Ufd1) (2) . It remains to be determined whether any of the p97 ubiquitous NH 2 domain binding proteins could play a role in the positive regulation of its ATPase activity. Interestingly, deletion of the NH 2 terminus does not influence p97 ATPase activity (20, 22, 33) . Our results also show that, like p97 R155P , p97 A232E displayed upregulated ATPase activity. The contribution of the D1 ring to p97 basal ATPase activity is unclear (24, 33) ; however, it is known to be activated in response to heat stimulation (24) . Our data show that the ATPase activities of both mutants are significantly upregulated at 42°C but do not rule out the ectopic activation of the D1 ring at 37°C. Accordingly, this increase in basal ATPase activity could be attributed to either D1 ring activation at 37°C or increased activity of the D2 ring, or both. On the other hand, the increased sensitivity to heat stimulation suggests alteration in the D1 ring function. Nevertheless, an increase in ATPase activity may detrimentally alter p97 cell biological activities by destabilizing p97-mediated protein interactions or, alternatively, by leading to the gain of new toxic functions (i.e., increasing binding affinity or promiscuity of p97/VCP-substrate interaction). Further studies are needed to address the mechanism by which hIBMPFTD mutations upregulate p97 ATPase activity and the possible implications for biological systems.
Evidence of structural defects in hIBMPFTD p97/VCP mutants p97 R155P and p97 A232E . Our results indicate that the Arg 155 and Ala 232 mutations influence distant residues within the p97 structure, a fact consistent with the dynamic nature of p97 interdomain communication (21, 22) . Considering that Trp 476 fluorescence has been used to report ATP-dependent conformational changes within the D2 ring (27) , our data suggest that p97 R155P and p97 A232E display different D2 ring conformations than p97
WT . We further defined the affected region between residues Lys 524 and Arg 709 , which covers part of the D2 ring and the COOH-terminal domain. The tryptic proteolysis assay showed that this region is more susceptible to proteolysis. Wang et al. previously demonstrated that p97 WT showed a large increase in protein fluorescence in response to ATP binding and that this was correlated with protection of the D2 ring from proteolysis (27) . While this is consistent with the results reported here, both p97 R155P and p97 A232E showed significantly higher ATP-dependent shifts in protein fluorescence than p97
WT with only partial D2 ring protection during the limited-proteolysis assay. It is possible that an elevated rate of nucleotide exchange may account for the increased proteolytic susceptibility of the D2 ring, especially since the p97 D2 ring adopts a flexible state directly following nucleotide release (5) . Alternatively, the increased ATPase activity may be consequential to structural defects imposed by mutations in residues Arg 155 and Ala 232 . In either case, the results indicate that the ATP-bound D2 ring adopts a relaxed conformation in p97 R155P and p97 A232E compared p97 WT . Interestingly, while p97 R155P displayed a larger change in protein fluorescence than p97 A232E , it was not correlated with faster proteolysis kinetics.
A possible explanation is that the Arg 155 mutation increases the affinity for nucleotide binding, as suggested by the strong protection of p58 during the limited-proteolysis assay. Nevertheless, both p97 R155P (8, 27) . It is also known that Arg 586 /Arg 599 adopt different localizations relative to the D2 pore during the ATPase cycle (5) . Thus, the conformational integrity of the D2 ring is necessary for proper substrate processing, and its perturbation in hIBMPFTD mutations may represent a possible mechanism of pathogenesis. Although it is still unclear if hIBMPFTD-linked p97 mutations influence the accessibility or function of the "denaturation collar," our data indicate that the overall conformational state of the D2 ring is altered in mutant p97 complexes. Indeed, hIBMPFTD-linked mutation in residue Arg155 (R155H) has been shown to impair the degradation of the ERAD substrate, ⌬F508-CFTR (cystic fibrosis transmembrane conductance regulator), in C2C12 skeletal myoblasts (30) . Future studies are necessary to substantiate whether all hIBMPFTD-linked p97 mutations result in similar alterations in the D2 ring conformation and if this is indeed a relevant mechanism of pathogenesis in vivo.
Consequences of hIBMPFTD mutations for the p97/VCP solution structure. DLS is a technique used to resolve particle size distribution in solution. Our analysis clearly showed a didispersed distribution consisted of assembled p97/VCP and large-diameter species. The hydrated diameter of p97, estimated at 20 to 25 nm, is consistent with published structural data (22) . Remarkably, we showed an ATP-dependent increase in the light-scattering intensity of the large-diameter population in samples containing p97 R155P and p97 A232E , but not p97
WT or p97 K524A . Considering that there was no significant increase in diameter, the increase in the light-scattering intensity should be attributed to increased abundance of the large-diameter species. This finding appears at odds with our EM images, which show assembled, ring-shaped p97/VCP in the presence of ATP. However, it is important to note that the percent intensity measurements in DLS do not reflect the actual proportion of the large-diameter species versus hexameric p97 particles and that DLS detects large-diameter species with high sensitivity. Overall, based on the EM study and the ATPase activity analyses, we conclude that hexameric p97 R155P and p97 A232E remain the predominant populations. However, in solution, p97 R155P and p97 A232E show an ATP-dependent propensity to assemble into large-diameter particles. The fact that the estimated diameter of these particles was ϳ10 times larger than the diameter of the assembled hexamers poses the possibility of ATP-mediated aggregate formation. Alternatively, the large-diameter particles may represent a population of transiently interacting p97 hexamers.
Together, these biochemical data provide the first evidence of structural defects associated with hIBMPFTD p97 mutations. Importantly, these defects were correlated with increased ATPase activity and alterations in the mutant p97 solution structure. It remains unclear whether these defects could be generalized to other hIBMPFTD p97 mutations, especially since both mutations, R155P and A232E, are relatively rare (13) . It is known that some p97 mutants, such as p97 R95G and p97 R155H , show reduced solubility in cell culture models (30) . Consistently, our initial analysis of p97 R95G expression in recombinant expression systems also showed reduced solubility (unpublished data). Thus, it remains to be seen if this effect is secondary to structural and biochemical defects such as those reported here. We propose that hIBMPFTD mutations influence the D2 ring conformation by increasing its flexibility and reducing its compactness upon ATP binding. Considering the newly proposed role of the D2 ring in the processing of protein substrates (6, 8) , these defects may have detrimental consequences for p97 cell biological functions.
